Picture of Catalent logo

CTLT Catalent Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapNeutral

Annual income statement for Catalent, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

2019
June 30th
2020
June 30th
2021
June 30th
2022
June 30th
2023
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K/A10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue2,5183,0943,9984,8024,263
Cost of Revenue
Gross Profit8059831,3521,6141,040
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses2,2602,7163,1884,0764,426
Operating Profit258378810726-163
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes160260715579-342
Provision for Income Taxes
Net Income After Taxes137221585499-256
Net Income Before Extraordinary Items
Net Income137221585499-256
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income137173529483-256
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS1.151.292.412.93-0.071